+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-16Number of Pages: 133

Photopheresis Products Market (Product Type - Open System and Closed System; End User - Hospitals and Clinics; Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections, and Autoimmune Diseases) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Photopheresis Products Market: Snapshot

Photopheresis has emerged as one of the most effective treatment options for a number of autoimmune diseases, chronic graft versus host disease, solid organ transplant rejections, and advanced cutaneous T-cell lymphoma in the past few years. The therapy, which was approved by FDA in 1988, is being largely considered as the first line of treatment for a number of diseases owing to benefits such as low rate of side effects, better safety, and efficacy as compared to other drug treatments. With the growing demand for blood derived products, the photopheresis product market is expected to gain significant traction during the forecast period.

Transparency Market Research estimates that the global photopheresis products market will exhibit a 5.9% CAGR over the period between 2016 and 2024. At this pace, the market, which had a valuation of US$223.1 mn in 2015, is expected to rise to US$ 371.1 mn by 2024.

Closed System Photopheresis Products to Account for Bulk of Revenues

The key varieties of photopheresis systems currently available in the market fall in two main categories: open system and closed system. Of these, the products falling under the category of closed systems are widely used by the healthcare practitioners as these products offer advantages such as less risk of infection and contamination, reduced treatment time, and easy treatment procedure over open systems. Moreover, closed system photopheresis devices are the only devices approved by the FDA for the treatment of CTL conditions. Around 70-80% of the overall photopheresis devices in the global market presently are closed systems and the rest of open system photopheresis devices.

The segment of closed systems, hence, accounted for the dominant 81.1% of the overall market in 2015, in terms of contribution of revenue to the global market. The segment is also expected to expand at a higher rate that the segment of open systems over the forecast period. The technologically advanced system and one-step procedure are some of the key reason for the higher adoption of these systems. However, high cost of these system could hinder the market growth during the forecast period.
photopheresis products market

 

Accounting for More than Half the Global Market, North America to Continue to Remain Dominant

North America leads the global photopheresis products market, accounting for over half of the market in 2015. The region is projected to retain its dominance during the forecast period as well. The vast reimbursement provided by governments for various disease indications such as GVHD, CTL, and lung transplantations treated by ECP therapy is a key factor contributing to the region’s leading position in the global market.

In 2012, Medicare extended reimbursement coverage for ECP therapy to treat bronchiolitis obliterans syndrome (BOS), a chronic lung allograft transplant dysfunction. Despite having vast growth opportunities, the lack of sufficient treatment centers for ECP therapy is expected to slow down the photopheresis products market in North America. Nevertheless, the comparatively more positive factors will grant favorable growth opportunities and the North America photopheresis market will exhibit a remarkable 5.8% CAGR over the period between 2016 and 2024.

However, Asia Pacific will overtake North America to take the lead in terms of rate of expansion of the photopheresis products market over the forecast period. The Asia Pacific market for photopheresis products, which held only about 4% of the global market in 2015, is expected to exhibit the leading 6.6% CAGR from 2016 through 2024. Expanding photopheresis centers in the region will be the key driving force of the market over the said period. Some of the other contributing factors are the faster regulatory approvals, increased acceptance of advanced photopheresis devices, and corporate entities boosting research activities in the ECP sector.

Key players in the global photopheresis market include Macopharma, Med Tech Solutions GmbH, Haemonetics Corporation, Fresenius Kabi AG, Terumo Corporation, and Mallinckrodt Pharmaceuticals. 

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Photopheresis Market

4. Market Overview
     4.1. Introduction
            4.1.1. By Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
            4.3.1. Region/Country Specific
            4.3.2. Product/Application/Therapeutic Area Specific
            4.3.3. Target Market Specific – Global Scenario
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.4. Global Photopheresis Products Market Forecast, 2016-2026
            4.4.1. Market Size Forecast
            4.4.2. Pipeline Analysis
     4.5. Organ and Stem Cell Transplantations Overview
     4.6. Photopheresis Therapy Snapshot
     4.7. Global Photopheresis Market Analysis and Forecasts, 2016–2024
            4.7.1. Market Revenue Projections (US$ Mn)
     4.8. Photopheresis Market - Global Supply Demand Scenario
     4.9. Porter’s Five Force Analysis
     4.10. Market Outlook

5. Global Photopheresis Market Analysis and Forecasts, By Product 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market value Forecast By Product, 2016–2024
            5.4.1. Open ECP system
            5.4.2. Closed ECP system
     5.5. By Product Comparison Matrix
     5.6. Market Attractiveness By Product 

6. Global Photopheresis Market Analysis and Forecasts, By End User 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market value Forecast By End User, 2016–2024
            6.4.1. Hospitals
            6.4.2. Specialty Clinics
     6.5. End User Comparison Matrix
     6.6. Market Attractiveness By End User 

7. Global Photopheresis Market Analysis and Forecasts, By Therapeutic Area 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market value Forecast By Therapeutic Area, 2016–2024
            7.4.1. Cutaneous T-cell Lymphoma
            7.4.2. Graft-versus-Host Disease
            7.4.3. Transplantation rejection
            7.4.4. Autoimmune Disease
     7.5. Therapeutic Area Comparison Matrix
     7.6. Market Attractiveness By Therapeutic Area 

8. Global Photopheresis Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market value Forecast By Region
            8.3.1. North America 
            8.3.2. Latin America 
            8.3.3. APAC 
            8.3.4. Europe 
            8.3.5. MEA 
     8.4. Market Attractiveness By Country/Region

9. North America Photopheresis Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Policies and Regulations
            9.1.3. Price Trend Analysis
            9.1.4. Key Trends
     9.2. Market value Forecast By Product, 2016–2024
            9.2.1. Open ECP system
            9.2.2. Closed ECP system
     9.3. Market value Forecast By End User, 2016–2024
            9.3.1. Hospitals
            9.3.2. Specialty Clinics
     9.4. Market value Forecast By Therapeutic Area, 2016–2024
            9.4.1. Cutaneous T-cell Lymphoma
            9.4.2. Graft-versus-Host Disease
            9.4.3. Transplantation rejection
            9.4.4. Autoimmune Disease
     9.5. Market value Forecast By Country, 2016–2024
            9.5.1. US
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Product 
            9.6.2. By End User 
            9.6.3. By Therapeutic Area 
            9.6.4. By Country

10. Latin America Photopheresis Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
            10.1.3. Price Trend Analysis
            10.1.4. Key Trends
     10.2. Market value Forecast By Product, 2016–2024
            10.2.1. Open ECP system
            10.2.2. Closed ECP system
     10.3. Market value Forecast By End User, 2016–2024
            10.3.1. Hospitals
            10.3.2. Specialty Clinics
     10.4. Market value Forecast By Therapeutic Area, 2016–2024
            10.4.1. Cutaneous T-cell Lymphoma
            10.4.2. Graft-versus-Host Disease
            10.4.3. Transplantation rejection
            10.4.4. Autoimmune Disease
     10.5. Market value Forecast By Country, 2016–2024
            10.5.1. Brazil
            10.5.2. Mexico
            10.5.3. Rest of Latin America
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product 
            10.6.2. By End User 
            10.6.3. By Therapeutic Area 
            10.6.4. By Country

11. APAC Photopheresis Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
            11.1.3. Price Trend Analysis
            11.1.4. Key Trends
     11.2. Market value Forecast By Product, 2016–2024
            11.2.1. Open ECP system
            11.2.2. Closed ECP system
     11.3. Market value Forecast By End User, 2016–2024
            11.3.1. Hospitals
            11.3.2. Specialty Clinics
     11.4. Market value Forecast By Therapeutic Area, 2016–2024
            11.4.1. Cutaneous T-cell Lymphoma
            11.4.2. Graft-versus-Host Disease
            11.4.3. Transplantation rejection
            11.4.4. Autoimmune Disease
     11.5. Market value Forecast By Country, 2016–2024
            11.5.1. Japan
            11.5.2. India
            11.5.3. China
            11.5.4. Rest of APAC
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product 
            11.6.2. By End User 
            11.6.3. By Therapeutic Area 
            11.6.4. By Country

12. Europe Photopheresis Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
            12.1.3. Price Trend Analysis
            12.1.4. Key Trends
     12.2. Market value Forecast By Product, 2016–2024
            12.2.1. Open ECP system
            12.2.2. Closed ECP system
     12.3. Market value Forecast By End User, 2016–2024
            12.3.1. Hospitals
            12.3.2. Specialty Clinics
     12.4. Market value Forecast By Therapeutic Area, 2016–2024
            12.4.1. Cutaneous T-cell Lymphoma
            12.4.2. Graft-versus-Host Disease
            12.4.3. Transplantation rejection
            12.4.4. Autoimmune Disease
     12.5. Market value Forecast By Country, 2016–2024
            12.5.1. UK
            12.5.2. France
            12.5.3. Germany
            12.5.4. Spain
            12.5.5. Italy
            12.5.6. Russia
            12.5.7. Rest of Europe
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product 
            12.6.2. By End User 
            12.6.3. By Therapeutic Area 
            12.6.4. By Country

13. MEA Photopheresis Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
            13.1.2. Policies and Regulations
            13.1.3. Price Trend Analysis
            13.1.4. Key Trends
     13.2. Market value Forecast By Product, 2016–2024
            13.2.1. Open ECP system
            13.2.2. Closed ECP system
     13.3. Market value Forecast By End User, 2016–2024
            13.3.1. Hospitals
            13.3.2. Specialty Clinics
     13.4. Market value Forecast By Therapeutic Area, 2016–2024
            13.4.1. Cutaneous T-cell Lymphoma
            13.4.2. Graft-versus-Host Disease
            13.4.3. Transplantation rejection
            13.4.4. Autoimmune Disease
     13.5. Market value Forecast By Country, 2016–2024
            13.5.1. South Africa
            13.5.2. Saudi Arabia
            13.5.3. UAE
            13.5.4. Rest of MEA
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product 
            13.6.2. By End User 
            13.6.3. By Therapeutic Area 
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis By Company (2015)
     14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. Haemonetics Corporation 
                      14.3.1.1. Company Overview
                      14.3.1.2. Financial Overview
                      14.3.1.3. Product Portfolio
                      14.3.1.4. Business Strategies
                      14.3.1.5. Recent Developments 
            14.3.2. Fresenius Kabi AG
                      14.3.2.1. Company Overview
                      14.3.2.2. Financial Overview
                      14.3.2.3. Product Portfolio
                      14.3.2.4. Business Strategies
                      14.3.2.5. Recent Developments 
            14.3.3. Macopharma
                      14.3.3.1. Company Overview
                      14.3.3.2. Financial Overview
                      14.3.3.3. Product Portfolio
                      14.3.3.4. Business Strategies
                      14.3.3.5. Recent Developments 
            14.3.4. Terumo Corporation
                      14.3.4.1. Company Overview
                      14.3.4.2. Financial Overview
                      14.3.4.3. Product Portfolio
                      14.3.4.4. Business Strategies
                      14.3.4.5. Recent Developments 
            14.3.5. Med Tech Solutions GmbH 
                      14.3.5.1. Company Overview
                      14.3.5.2. Financial Overview
                      14.3.5.3. Product Portfolio
                      14.3.5.4. Business Strategies
                      14.3.5.5. Recent Developments 
            14.3.6. Mallinckrodt Pharmaceuticals 
                      14.3.6.1. Company Overview
                      14.3.6.2. Financial Overview
                      14.3.6.3. Product Portfolio
                      14.3.6.4. Business Strategies
                      14.3.6.5. Recent Developments 

List of Figures

Figure 01: Global Photopheresis Products Market Size (US$ Mn) Forecast, 2015–2024
Figure 02: Figure 02: Clinical Trials Conducted, by Region (%)
Figure 03: No. of Clinical Trials Carried Out by Academics/Industry
Figure 04: No. of Clinical Trials in Different Phases
Figure 05: No. of Clinical Trials on Disease Indication
Figure 06: Global Organ Transplantations, by Region (%), (2014)
Figure 07: Global Organ Transplantations Volume (2010–2014)
Figure 08: Global Lung Transplantations, by Region (%), (2014)
Figure 09: Global Lung Transplantations Volume (2010–2014)
Figure 10: Global Liver Transplantations, by Region (%), (2014)
Figure 11: Global Liver Transplantations Volume (2010–2014)
Figure 12: Global Kidney Transplantations, by Region (%), (2014)
Figure 13: Global Kidney Transplantation Volume (2010–2014)
Figure 14: Global Stem Cell Transplants, by Type (1996–2012)
Figure 15: Global Stem Cell Transplants Volume (1996–2012)
Figure 16: Global Stem Cell Transplants, by Region (%) (2006–2012)
Figure 17: Regional Stem Cell Transplants Volume (2006–2012)
Figure 18: Global Photopheresis Products Market Value Share By Product (2016)
Figure 19: Global Photopheresis Products Market Value Share By Therapeutic Area (2016)
Figure 20: Global Photopheresis Products Market Value Share By Region (2016)
Figure 21: Global Photopheresis Products Market Value Share By End User (2016)
Figure 22: Global Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 23: Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 24: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Open System, 2015–2024
Figure 25: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Closed System, 2015–2024
Figure 26: Global Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2024
Figure 27: Global Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2015
Figure 28: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Cutaneous T-cell Lymphoma, 2015–2024
Figure 29: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Graft-versus-Host Disease, 2015–2024
Figure 30: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Transplant Rejections, 2015–2024
Figure 31: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Autoimmune Diseases, 2015–2024
Figure 32: Global Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2024
Figure 33: Global Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 34: Global Photopheresis Products Market Revenue (US$ Mn) and
Figure 35: Global Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Specialty Clinics, 2015–2024
Figure 36: Global Photopheresis Products Market Value Share Analysis, by Region, 2016 and 2024
Figure 37: Photopheresis Products Market Attractiveness Analysis, by Region
Figure 38: North America Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y, 2015–2024
Figure 39: North America Photopheresis Products Market Attractiveness Analysis, by Country,2015
Figure 40: North America Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 41: North America Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 42: North America Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2026
Figure 43: North America Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area
Figure 44: North America Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2026
Figure 45: North America Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 46: Europe Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y 2015–2024
Figure 47: Europe Photopheresis Products Market Attractiveness Analysis, by Country, 2015–2024
Figure 48: Europe Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 49: Europe Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 50: Europe Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2026
Figure 51: Europe Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2015
Figure 52: Europe Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2026
Figure 53: Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 54: Latin America Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y , 2015–2024
Figure 55: Latin America Photopheresis Products Market Attractiveness Analysis, by Region ,2015
Figure 56: Latin America Photopheresis Products Market Value Share Analysis by Product Type, 2016 and 2026
Figure 57: Latin America Photopheresis Products Market Attractiveness Analysis, by Product Type,2015
Figure 58: Latin America Photopheresis Products Market Value Share Analysis By Therapeutic Area, 2016 and 2026
Figure 59: Latin America Photopheresis Products Market Attractiveness Analysis by Therapeutic Area, 2015
Figure 60: Latin America Photopheresis Products Market Value Share Analysis by End User, 2016 and 2026
Figure 61: Latin America Photopheresis Products Market Attractiveness Analysis by End User, 2015
Figure 62: Asia Pacific Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y, 2015–2024
Figure 63: Asia Pacific Photopheresis Products Market Attractiveness Analysis, by Region, 2015
Figure 64: Asia Pacific Photopheresis Products Market Value Share Analysis by Product Type, 2016 and 2026
Figure 65: Asia Pacific Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 66: Asia Pacific Photopheresis Products Market Value Share Analysis by Therapeutic Area, 2016 and 2026
Figure 67: Asia Pacific Photopheresis Products Market Attractiveness Analysis, By Therapeutic Area, 2015
Figure 68: Asia Pacific Photopheresis Products Market Value Share Analysis by End User, 2016 and 2026
Figure 69: Asia Pacific Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 70: Middle East & Africa Photopheresis Products Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2024
Figure 71: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Country, 2015
Figure 72: Middle East & Africa Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 73: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 74: Middle East & Africa Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2024
Figure 75: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2015
Figure 76: Middle East & Africa Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2024
Figure 77: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 78: Photopheresis Products Market Share Analysis, by Company (2015)

List of Tables

Table 01 Global Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 02 Global Photopheresis Products Market Size (US$ Mn), by Therapeutic Area, 2015–2024
Table 03 Global Photopheresis Products Market Size (US$ Mn) Forecast, by End User, 2015–2024
Table 04 Global Photopheresis Products Market Size (US$ Mn) Forecast, by Region, 2015–2024
Table 05 North America Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 06 North America Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2015–2024
Table 07 North America Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2015–2024
Table 08 North America Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024
Table 09 Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 10 Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2015–2024
Table 11 Europe Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2015–2024
Table 12 Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13 Latin America Photopheresis Products Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 14 Latin America Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2015–2024
Table 15 Latin America Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2015–2024
Table 16 Latin America Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024
Table 17 Asia Pacific Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 18 Asia Pacific Photopheresis Products Market Size (US$ Mn) Forecast, By Therapeutic Area, 2015–2024
Table 19 Asia Pacific Photopheresis Products Market Size(US$ Mn) Forecast, by Product Type, 2015–2024
Table 20 Asia Pacific Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024
Table 21 Middle East & Africa Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 22 Middle East & Africa Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2014–2024
Table 23 Middle East & Africa Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2014–2024
Table 24 Middle East & Africa Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024

Global Photopheresis Products Market: Overview

The photopheresis products market is mainly driven by growing Graft versus host disease conditions globally. Furthermore the rising coverage of healthcare and increasing in transplantations expected to grow photopheresis products market growth. However, the market growth is hindered by lack of many photopheresis treatment centers and high cost involved in therapy. In the U.S., ECP therapy costs around US$8000/treatment and every individual has to take the treatment for every two weeks and continue the same procedure for one year to complete the treatment. According to research article, globally, around 26% to 36% recipients of full matched sibling donor grafts suffer from acute graft versus host disease conditions. Photopheresis therapy is a U.S FDA approved treatment to treat cutaneous T-cell lymphoma conditions.

However, it is most commonly used in treating graft versus host disease conditions. Furthermore, in 2016, Swedish government has given reimbursement for lung transplantations by using photopheresis therapy. Currently few clinical trials are undergoing on photopheresis therapy to explore its benefits to treat autoimmune disease conditions. Treatment of autoimmune diseases using photopheresis therapy is still in nascent phase. Mallinckrodt pharmaceuticals is actively conducting clinical trials on novel therapeutic indications like Cohn’s disease, multiple sclerosis conditions and more over. In 2015, Therakos Inc., was acquired by Mallinckrodt to strengthen its revenue generation from hospital segment. Based on the product type, photopheresis products are segmented into open systems and closed systems. Closed systems are mostly used globally to treat various disease conditions and these are technologically advanced systems than the open systems. In USA, closed systems dominates the market and they are approved by U.S FDA to treat cutaneous T-cell lymphoma conditions. In Europe, both closed systems and open systems are commonly preferred to treat various disease conditions.

Global Photopheresis Products Market: Scope of the Report

The report is a combination of primary and secondary research. Primary research formed the bulk of our research efforts, with information collected from telephonic interviews and interactions via e-mail. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various national and international databases. The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2024, considering the macro and micro-environmental factors. Growth rates for each segment within the photopheresis products market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, vaccination expenditure, and regulatory requirements.

The market overview section of the report includes qualitative analysis of the photopheresis products market including the determining factors and market dynamics such as drivers, restraints, market trends and opportunities, along with white space analysis. In addition, market attractiveness analysis by country, isotopic application and end-user along with competitive landscape by key players have been provided which explain the intensity of competition in the market considering different geographical locations. The competitive scenario between market players has been evaluated through market share analysis. These factors would help the market players take strategic decisions in order to strengthen their positions and increase their shares in the global market.

Global Photopheresis Products Market: Geographical and Competitive Dynamics

The market is driven by increase in graft versus host disease conditions and novel benefits of photopheresis therapy in different therapeutic indications. The market is expected to grow due to favorable reimbursement scenario in various countries for photopheresis therapy. In terms of End user, specialty clinics are less preferred when compared with hospitals. This is mainly due to the high cost of the photopheresis products which can only afford by the hospitals.

Geographically, the global photopheresis products market has been segmented into five regions with North America leading the market in 2015 followed by Europe and Asia Pacific. The requirement for photopheresis products are rapidly growing in Asia Pacific due to increase in transplantations and penetration of key market players entering into this geography are expected to drive the growth of this market during the forecast period.

Key companies profiled in the report include Macopharma, Med Tech Solutions GmbH, Haemonetics Corporation, Fresenius Kabi AG, Terumo Corporation, and Mallinckrodt Pharmaceuticals

The photopheresis products market has been segmented as follows:

Global Photopheresis products Market, by Product

  • Open system
  • Closed system

Global photopheresis products market, by Therapeutic Area

  • Graft versus host disease
  • Transplant rejections
  • Autoimmune diseases
  • Cutaneous T-cell lymphoma

Global photopheresis products market, by End User

  • Hospitals
  • Specialty clinics

Global photopheresis products market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA (Middle East & Africa)


 
 
Back To Top